KPTI vs XOM · rev $68.5M vs P/E 24, rev $201.16B
Karyopharm Therapeutics Inc (KPTI) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren W. Woods.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
KPTI currently screens at market cap $205.6M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the KPTI and XOM stock pages for the full models.
Not investment advice.